Dr. Gil Sambrano, Vice President Portfolio & Review All this month we are using our blog and social media to highlight a new chapter in CIRM’s life, thanks to the voters approving Proposition 14. We are looking back at what we have done since we were created in 2004, and also looking forward to the … Continue reading Month of CIRM: Reviewing Review
Events
A Month of CIRM: Where we’ve been, where we’re going
All this month we are using our blog and social media to highlight a new chapter in CIRM’s life, thanks to the voters approving Proposition 14. We are looking back at what we have done since we were created in 2004, and also looking forward to the future. We kick off this event with a … Continue reading A Month of CIRM: Where we’ve been, where we’re going
Building Bridges to a Brighter Future – Celebrating 11 Years of Workforce Development
By: Dr. Kelly Shepard, Associate Director, Discovery and Translation, CIRM CIRM 2020 Bridges Conference via Zoom Every July, CIRM is thrilled to announce the arrival a new generation of stem cell scientists who are ready to hit the ground running as laboratory technicians, educators, communicators, or future leaders of their chosen profession. These diverse and … Continue reading Building Bridges to a Brighter Future – Celebrating 11 Years of Workforce Development
Perseverance: from theory to therapy. Our story over the last year – and a half
Some of the stars of our Annual Report It’s been a long time coming. Eighteen months to be precise. Which is a peculiarly long time for an Annual Report. The world is certainly a very different place today than when we started, and yet our core mission hasn’t changed at all, except to spring into … Continue reading Perseverance: from theory to therapy. Our story over the last year – and a half
A new voice and vision added to CIRM Board
UC Davis School of Medicine Dean, Dr. Allison Brashear: Photo courtesy UCD We have a new member on the CIRM Board – Dr. Allison Brashear is the Dean of the UC Davis School of Medicine, overseeing one of the nation’s top research, academic and medical training institutions. Dr. Brashear is an internationally known researcher in … Continue reading A new voice and vision added to CIRM Board
Saying farewell to an old friend
There are some people who, when you think of them, always bring a smile to your face. Dr. Bert Lubin was one of those people. Sadly, we lost Bert to brain cancer two days ago. But the impact he had, not just as an advocate for stem cell research but as a pioneer in sickle … Continue reading Saying farewell to an old friend
CIRM Board Expands Efforts of COVID-19 Program
Today the governing Board of the California Institute for Regenerative Medicine (CIRM) expanded efforts related to the $5 million in emergency funding for the CIRM COVID-19 program. The new guidelines mean that inception discovery projects (DISC1), whose goal is developing new and transformational ideas, will now be eligible for CIRM COVID-19 funding. These projects can … Continue reading CIRM Board Expands Efforts of COVID-19 Program
CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
Coronavirus particles, illustration. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved new clinical trials for COVID-19 and sickle cell disease (SCD) and two earlier stage projects to develop therapies for COVID-19. Dr. Michael Mathay, of the University of California at San Francisco, was awarded $750,000 for a clinical trial testing … Continue reading CIRM Board Approves Clinical Trials Targeting COVID-19 and Sickle Cell Disease
Cashing in on COVID-19
Coronavirus particles, illustration. Courtesy KTSDesign/Science Photo Library As the coronavirus pandemic continues to spread, one of the few bright spots is how many researchers are stepping up and trying to find new ways to tackle it, to treat it and hopefully even cure it. Unfortunately, there are also those who are simply trying to cash … Continue reading Cashing in on COVID-19
An advocate’s support for CIRM’s COVID-19 funding
Patient Advocates play an important role in everything we do at the stem cell agency, helping inform all the decisions we make. So it was gratifying to hear from one of our Advocates par excellence, Adrienne Shapiro, about her support for our Board's decision to borrow $4.2 million from our Sickle Cell Cure fund to … Continue reading An advocate’s support for CIRM’s COVID-19 funding